STOCK TITAN

Belite Bio (BLTE) EPS by Year

BLTE NASDAQ

Belite Bio, Inc lost $2.31 per diluted share in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 6 fiscal years, from 2020 to 2025.

FY2025 annual
EPS (Diluted) -$2.31
YoY n/m
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

BLTE EPS (Diluted) by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-F
EPS (Diluted)-$2.31n/m-$1.18n/m-$1.19n/m-$0.63-$1.01n/m-$0.65

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Belite Bio, Inc financials

Frequently Asked Questions

Belite Bio, Inc lost $2.31 per diluted share in fiscal year 2025.

Belite Bio, Inc (BLTE) reported a loss of $1.18 per diluted share in fiscal year 2024 and a loss of $2.31 per diluted share in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

Across the 6 fiscal years this page covers, Belite Bio, Inc (BLTE) diluted earnings per share went from -$0.65 in fiscal year 2020 to -$2.31 in fiscal year 2025.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Belite Bio, Inc (BLTE) reported on that line in every period on record.